Aller au contenu principal
2020 conference-abstract

CblX is a New Cobalamin Syndrome Affecting Craniofacial Development

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : us, ca. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Combined methylmalonic acidemia and homocystinuria ( cblC type), an inherited disorder of cobalamin (vitamin B 12 ) metabolism, is a rare metabolic and multi‐systemic disease caused by mutations in MMACHC . Patients with cblC can have severe neurodevelopmental defects including microcephaly, hydrocephaly, and seizures as well as renal, cardiac and hematological defects. Recently, two new variants of cblC were discovered and termed cblX and cblX ‐like. Rather than being due to mutations in MMACHC , cblX and cblX ‐like result from homozygous mutations in the transcription cofactor HCFC1 and its transcription factor partner RONIN (THAP11) , respectively. Patients with either HCFC1 or RONIN mutations were shown to have a dramatic reduction in MMACHC transcription. We have known that HCFC1 is an obligatory partner for RONIN and we have previously shown that the HCFC1/RONIN transcriptional complex directly regulates mouse Mmachc expression. These findings suggest that cblX and cblX ‐like disorders comprise a novel family of rare and severe cblC ‐like disorders that are transcriptional in nature. To better understand the cellular and molecular mechanisms underlying the pathophysiology of these devastating neurodevelopmental diseases, we have generated Hcfc1 A115V and Ronin F80L mice, which have the same point mutations observed in cblX and cblX ‐like patients. Both Hcfc1 Y/A115V hemizygous and Ronin F80L/F80L homozygous mice exhibit defects in cobalamin metabolism consistent with an inherited vitamin B 12 disorder, as well as defects that recapitulate those observed in the human cblX and cblX ‐like patients, including severe brain developmental defects, cardiac malformations, and anemia. Additionally, these mice also exhibit craniofacial deformities, a developmental phenotype that has not been previously linked to vitamin B 12 . Our data identifies, for the first time, a role for RONIN/HCFC1 in craniofacial development. Together, the phenotypic and molecular data confirm that the Ronin F80L and Hcfc1 A115V mouse models will serve as powerful tools to further uncover the pathophysiology of this complex family of diseases, as well as to achieve a better understanding of the complexities of craniofacial development. Support or Funding Information This work is supported by R01 DE028298.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
<i>CblX</i> is a New Cobalamin Syndrome Affecting Craniofacial Development
Date Crossref
01/04/2020
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Folate and B Vitamins ResearchMetabolism and Genetic DisordersPorphyrin Metabolism and Disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.